Cynaptec Pharmaceuticals
Cynaptec Pharmaceuticals is a startup headquartered in Stuart, United States, founded in 2025. It has raised at least $6.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Cynaptec Pharmaceuticals has raised at least $6.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Cynaptec Pharmaceuticals sits inside the Jupiter region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Stuart
Related
Questions and answers
What does Cynaptec Pharmaceuticals do?
Cynaptec Pharmaceuticals is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Cynaptec Pharmaceuticals raised?
At least $6.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Cynaptec Pharmaceuticals based?
Cynaptec Pharmaceuticals is headquartered in Stuart, United States.
When was Cynaptec Pharmaceuticals founded?
Cynaptec Pharmaceuticals was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.